Call Me Stormy

Finding righteous currents in turbulent times

Death By Remdesivir

Robert F. Kennedy Jr. tells London Real that for all the wealth equality that liberals blab about, they still fail to take accountability for the disaster that was their Covid-19 pandemic hoax.

Kennedy says the lockdowns and restrictions not only hurt the poor, they also enriched the super wealthy by $3.9 million, creating 500 new billionaires. “It was a war on the poor and the children,” he says. He added that Blacks suffered three times the death rate of whites and the United States, which has 4.2 percent of the global population, suffered 20 percent of Covid deaths.

“Our country had the strictest adherence to all these protocols, including the use of Remdesivir, which is enormously toxic and completely inefficacious, but it was Tony Fauci’s pet drug,” Kennedy says. Despite the facts and the overwhelming evidence, the left, with help from the complicit mainstream media, refused to take responsibility. More from Kennedy.




Spread the word

Single Post Navigation

2 thoughts on “Death By Remdesivir

  1. Ronald M. Chavin on said:

    Remdesivir failed to shorten hospital stays or reduce deaths in these clinical trials:
    https://www.medrxiv.org/content/10.1101/2021.03.09.21253183v1.full
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439621/
    https://www.medrxiv.org/content/10.1101/2022.03.30.22273206v1.full
    https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1.full
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279143/
    https://rebelem.com/remdesivir-in-moderate-covid-19/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190303/
    https://pubmed.ncbi.nlm.nih.gov/32423584/
    https://pubmed.ncbi.nlm.nih.gov/33521757/
    https://www.researchsquare.com/article/rs-894056/v1
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993042/
    https://journals.lww.com/lungindia/Fulltext/2022/01000/Effectiveness_of_remdesivir_on_hospital_stay.19.aspx
    https://www.medrxiv.org/content/10.1101/2021.08.13.21261992v1
    https://pubmed.ncbi.nlm.nih.gov/33219182/
    https://pubmed.ncbi.nlm.nih.gov/34501233/
    https://www.medrxiv.org/content/10.1101/2021.07.01.21259852v1.full
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283561/
    https://www.medrxiv.org/content/10.1101/2021.02.10.21251527v1.full
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525677/
    https://www.sciencedirect.com/science/article/pii/S1876034121003452
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0264301
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899883/
    https://pubmed.ncbi.nlm.nih.gov/35500262/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177180/
    https://link.springer.com/article/10.1007/s40620-022-01364-3
    https://c19early.com/okus.html

    The researchers who completed the 1,643-participant, New York City remdesivir clinical trial imply that in the ACTT-1 clinical trial, the sicker patients must have been sneaked into the placebo group to get the rigged result that got remdesivir approved:
    https://www.medrxiv.org/content/10.1101/2020.08.10.20171637v1
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734451/

    In the following studies, favipiravir outperformed remdesivir for early COVID-19 efficacy, late COVID-19 efficacy, milder side effects, lower price, better convenience, or higher compliance:
    https://journal.fkm.ui.ac.id/kesmas/article/view/5433
    https://www.centerwatch.com/clinical-trials/listings/260496/efficacy-of-favipiravir-in-treatment-of-mild-moderate-covid-19-infection-in-nepal/
    https://onlinelibrary.wiley.com/doi/10.1111/resp.14150_15
    https://www.researchgate.net/publication/348578493_Remdesivir_and_Favipiravir_Changes_Hepato-Renal_Profile_in_COVID-19_Patients_A_Cross_Sectional_Observation_in_Bangladesh
    https://www.medrxiv.org/content/10.1101/2021.03.05.21251351v1.full
    https://pubmed.ncbi.nlm.nih.gov/33518623/
    https://www.medrxiv.org/content/10.1101/2022.02.11.22270775v1.full
    https://pubmed.ncbi.nlm.nih.gov/33705849/
    https://www.tandfonline.com/doi/full/10.1080/23744235.2022.2081716
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934715/
    https://pubmed.ncbi.nlm.nih.gov/35077495/
    https://pubmed.ncbi.nlm.nih.gov/35731976/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426393/

    Remdesivir failed in Japan for treating hamsters with COVID-19 but favipiravir did not fail:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805032/

    In a new study from Wuhan, China, after sacrificing hundreds of IFNAR1-/- (slightly immunocompromised) mice, both T-705 (favipiravir) and H44 (improved-molecule favipiravir derivative) defeated both EIDD-1931 (NHC = the metabolite) and EIDD-2801 (molnupiravir = the prodrug), which defeated GS-5734 (remdesivir), which finished in last place:
    https://www.sciencedirect.com/science/article/abs/pii/S0166354222000419

    Remdesivir is totally useless against all viral diseases, including the flu, common cold, and Ebola:
    https://www.nejm.org/doi/full/10.1056/NEJMoa1910993
    https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2019/nejm_2019.381.issue-24/nejmoa1910993/20191206/images/img_xlarge/nejmoa1910993_f1.jpeg

    Remdesivir is fraudulently indicated for end-stage COVID-19 when in truth, it has absolutely no benefit in reducing the cytokine storm, in fact, might make it slightly worse:
    https://www.nature.com/articles/s41591-020-1051-9
    https://www.nature.com/articles/s41591-020-1051-9/figures/5
    https://www.mdpi.com/tropicalmed/tropicalmed-05-00112/article_deploy/html/images/tropicalmed-05-00112-g004.png

    Remdesivir causes numerous bizarre side effects, including acute pancreatitis, anaphylaxis, bacteremia, blisters, circadian rhythm dysfunction, exanthema, hyperglycemia, osmotic tubulopathy, reactivation of herpes, and skin rashes:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923226/
    https://pubmed.ncbi.nlm.nih.gov/33950198/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406697/
    https://www.researchgate.net/publication/344289753_Painful_Blisters_of_Left_Hand_following_Extravasation_of_Remdesivir_Infusion_in_COVID-19
    https://aac.asm.org/content/65/5/e00233-21
    https://pubmed.ncbi.nlm.nih.gov/33590992/
    https://www.nature.com/articles/s41598-022-09170-4
    https://pubmed.ncbi.nlm.nih.gov/36206474/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285716/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112887/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373689/
    https://pubmed.ncbi.nlm.nih.gov/34328807/
    https://journals.sagepub.com/doi/10.1177/10600280221096883
    https://pubmed.ncbi.nlm.nih.gov/35695412/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385380/

    Remdesivir causes blood clots (18.8% for remdesivir versus 5.3% for placebo), thereby making remdesivir even worse than baricitinib, ruxolitinib, tofacitinib, and dexamethasone for increasing the incidence of deadly blood clots during COVID-19:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658413/
    https://www.sciencedirect.com/science/article/pii/S1876034121003452
    https://link.springer.com/article/10.1007/s40264-021-01082-y/figures/1
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883150/
    https://www.sciencedirect.com/science/article/pii/S0953620520304064

    Remdesivir causes heart damage (asystolic arrest, cardiac arrest, heart block, hypotension, QT interval prolongation, sinus bradycardia) but favipiravir does not:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841455/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682945/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308754/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598346/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247739/
    https://www.sciencedirect.com/science/article/abs/pii/S0022073620305835
    https://pubmed.ncbi.nlm.nih.gov/26308176/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571425/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511861/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359645/
    https://onlinelibrary.wiley.com/doi/10.1002/clc.23700
    https://academic.oup.com/jpids/article/10/9/926/6309954
    https://casereports.bmj.com/content/14/9/e245289
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101980/
    https://pubmed.ncbi.nlm.nih.gov/33620107/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972361/
    https://www.sciencedirect.com/science/article/pii/S1198743X2100094X
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822751/
    https://pubmed.ncbi.nlm.nih.gov/33673216/
    https://pubmed.ncbi.nlm.nih.gov/34591799/
    https://pubmed.ncbi.nlm.nih.gov/34609482/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742862/
    https://www.cidrap.umn.edu/news-perspective/2020/06/study-heart-problems-covid-19-icu-patients-likely-not-due-virus
    https://www.cureus.com/articles/85015-remdesivir-associated-sinus-arrest-in-covid-19-a-potential-indication-for-close-cardiac-monitoring
    https://link.springer.com/article/10.1007/s40278-022-17256-9
    https://link.springer.com/article/10.1007/s15010-022-01854-3
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239507/
    https://www.sciencedirect.com/science/article/pii/S2214250922002001
    https://www.heartrhythmcasereports.com/article/S2214-0271(21)00100-7/fulltext
    https://www.ahajournals.org/doi/10.1161/CIRCEP.121.009811
    https://journals.lww.com/joacp/Fulltext/2022/00001/Remdesivir_induced_bradycardia_and_QT.35.aspx
    https://www.cureus.com/articles/99308-remdesivir-induced-marked-sinus-bradycardia-in-covid-19
    https://www.cureus.com/articles/105447-remdesivir-induced-extreme-sinus-bradycardia-in-covid-19
    https://www.biorxiv.org/content/10.1101/2022.08.08.503256v1.full
    https://link.springer.com/article/10.1007/s40261-022-01187-x
    https://onlinelibrary.wiley.com/doi/10.1002/advs.202203388
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438825/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464835/

    Remdesivir-induced bradycardia is sometimes just temporary, sometimes permanent:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675592/

    Remdesivir causes liver damage but favipiravir does not:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381904/
    https://www.gastroenterologyadvisor.com/liver/remdesivir-linked-to-poor-liver-associated-safety-profile-in-treatment-of-covid-19/
    https://pubmed.ncbi.nlm.nih.gov/33006138/
    https://pubmed.ncbi.nlm.nih.gov/35093272/
    https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2464
    https://link.springer.com/article/10.1007/s12072-020-10077-3
    https://academic.oup.com/jpids/article/10/9/926/6309954
    https://www.tandfonline.com/doi/full/10.1080/08998280.2021.1885289
    https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13313
    https://casereports.bmj.com/content/13/10/e239210
    https://pubmed.ncbi.nlm.nih.gov/33940227/
    https://theprint.in/health/govt-reviewing-remdesivir-use-for-covid-after-hospitals-report-liver-damage-in-patients/454169/
    https://www.newindianexpress.com/nation/2020/jul/11/centre-advises-cautious-use-of-remdesivir-tocilizumab-for-covid-19-treatment-2168422.html
    http://www.sciencepublishinggroup.com/journal/paperinfo?journalid=252&doi=10.11648/j.ajim.20200806.18
    https://www.nephropathol.com/Files/Inpress/jnp-17106.pdf
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426393/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509270/
    https://www.drugs.com/drug-interactions/paxlovid-with-remdesivir-4326-19915-4146-0.html
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116058/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534366/

    Remdesivir causes kidney damage but favipiravir does not:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990823/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907730/
    https://pubmed.ncbi.nlm.nih.gov/33340409/
    https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2587
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784780/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353611/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177613/
    https://pubmed.ncbi.nlm.nih.gov/34787281/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968134/
    https://theprint.in/health/cipla-to-experiment-with-change-in-covid-drug-remdesivir-recipe-to-reduce-effect-on-kidneys/571951/
    http://pharmabiz.com/NewsDetails.aspx?aid=134341&sid=1
    https://advances.massgeneral.org/research-and-innovation/article.aspx?id=1224
    https://www.rxlist.com/consumer_remdesivir_rdv/drugs-condition.htm
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110936/
    https://www.gileadproblems.com/?gclid=EAIaIQobChMI7PbR7OPI-QIVVQutBh1XRgH-EAAYASAAEgKYjPD_BwE

    Remdesivir, Kaletra, and ribavirin worsen the skin rash problem during COVID-19 but favipiravir does not:
    https://pubmed.ncbi.nlm.nih.gov/33301232/

    Remdesivir permanently damages the natural enzyme, CES-2, which is needed by the human body to convert biochemicals:
    https://medicalxpress.com/news/2020-12-urges-caution-remdesivir-covid-.html

    Because of remdesivir’s above-described adverse events, some of which might damage a person’s health permanently, the survivors in the placebo group are much better off than the survivors in the remdesivir group:
    https://ground.news/article/as-demand-drops-60l-remdesivir-vials-may-be-destroyed

    Among RdRp inhibitors, molnupiravir’s metabolite, EIDD-1931 (NHC), was highly mutagenic, ribavirin was slightly mutagenic, and favipiravir was not mutagenic at all in this North Carolina study, which forgot to include remdesivir:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136050/

    Among RdRp inhibitors, remdesivir might be almost as mutagenic as molnupiravir because it has triggered viral mutations in hospitalized COVID-19 patients:
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9378267/
    https://medicalxpress.com/news/2022-09-remdesivir-resistant-version-covid-transplant-recipients.html
    https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac769/6717535

    Remdesivir causes 362 bad drug interactions by interfering with hepatic cytochrome P450, notably the 3A4 subtype, CYP3A4, which is the key enzyme for metabolizing most drugs.
    P-glycoprotein (P-gp) is the name of the transporter which boosts the concentration of many drugs:
    https://www.drugs.com/drug-interactions/remdesivir.html
    https://pubmed.ncbi.nlm.nih.gov/35861498/

    Caution: Beer, wine, cigarettes, corticosteroids, remdesivir, and favipiravir will cause birth defects? More than 100 very popular drugs that have been approved worldwide, including statins for cholesterol, ACE inhibitors and ARBs for blood pressure, corticosteroids and NSAIDs for pain or inflammation, antibiotics for infections, progestins, anabolic steroids, methotrexate, anti-fungals, anti-virals, chemotherapy drugs, alcoholic drinks, tobacco, and ionizing radiation, ALL CAUSE BIRTH DEFECTS:
    https://www.researchgate.net/profile/Daryl_Lynch/publication/287212052/figure/tbl1/AS:669660978622474@1536671027816/Teratogenic-Medications-Queried-for-During-Study-Period.png
    http://www.emdocs.net/wp-content/uploads/2017/05/Screen-Shot-2017-05-09-at-12.48.32-AM-768×993.png
    https://www.sciencedirect.com/science/article/pii/S0301211521010009
    https://link.springer.com/article/10.1007/s00404-022-06615-z
    https://www.sciencedirect.com/science/article/pii/S2049080122004411
    https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/jat.4336
    https://www.sciencedirect.com/science/article/pii/S0890623822000806
    https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00276-6/fulltext

    Each time the heart-damaging drug, remdesivir, is dispensed, “royalties go to NIAID (Tony Fauci’s agency), the U.S. Army, and the hospitals:”
    https://merylnassmd.com/fda-approved-remdesivir-for-28-day-old/
    https://www.redvoicemedia.com/video/2022/04/child-sacrifice-the-fda-approved-remdesivir-based-on-a-trial-in-which-3-out-of-53-children-died/
    https://www.vax.guide/2022/05/11/covid-pills-cause-deadly-relapses-and-supercharge-mutations/
    https://www.theburningplatform.com/2022/05/11/covid-pills-cause-deadly-relapses-and-supercharge-mutations/
    https://childrenshealthdefense.org/defender/covid-pills-remdesivir-paxlovid-molnupiravir-cola/

    Dr. Paul Alexander, Kelly Ansems, Dr. Bryan Ardis, Dr. Scott Atlas, Dr. Amy Beard, Stephanie Brail, Jennifer Brown, JV Chamary, Sam Chaney, Igor Chudov, Dr. Ryan Cole, Peter Halligan, Daniel Horowitz, Ethan Huff, Dr. Robert Malone, Dr. Paul Marik, Dr. David Martin, Dr. Peter McCullough, Dr. Joseph Mercola, Dr. Peterson Pierre, Dr. Didier Raoult, Dr. Jane Ruby, Dr. Madhava Setty, Dr. Mark Sircus, Richard Willet, and Victoria Yan have strongly advised everybody to refuse the totally fraudulent drug, remdesivir, at the hospital. Each time they administer remdesivir, hospitals in the U.S. receive a huge, 20% financial kickback plus other bonuses from the U.S. government, which receives huge amounts of bribe money from U.S. Big Pharma, usually directly to both the visible and hidden accounts of the politicians who write the law:
    https://cdn1.lockerdome.com/uploads/b8240da3f5019f843cb35c16e4b6c0e07eee7ffcdb62a993824ee199de5fdc03_facebook
    https://www.gisreportsonline.com/wp-content/uploads/2021/07/tsunami_poverty-scaled.jpg
    https://crooksandliars.com/files/primary_image/19/04/tarbell.jpg

    Even Dr. Anthony Fauci has become anti-remdesivir:
    https://genesiustimes.com/fauci-abruptly-changes-course-on-ivermectin-remdesivir-after-contracting-covid/

    In Europe, ESICM now advises against remdesivir:
    https://wkzo.com/2020/11/13/worlds-top-intensive-care-body-advises-against-remdesivir-for-sickest-covid-patients/
    https://translate.google.com/translate?hl=en&sl=fr&u=https://1dex.ch/2020/11/le-scandale-du-remdesivir-ne-fait-que-commencer-lettre-ouverte-dun-citoyen-suisse/&prev=search&pto=aue
    https://www.forbes.com/sites/jvchamary/2021/01/31/remdesivir-covid-coronavirus/?sh=7806bce666c2
    https://journals.asm.org/doi/10.1128/AAC.01117-21

    *****************

Leave a Reply